Transmucosal oral delivery device

Details for Australian Patent Application No. 2005309652 (hide)

Owner Izun Pharmaceuticals Corporation

Inventors Saffer, Aron; Levine, William

Agent Callinan

Pub. Number AU-B-2005309652

PCT Pub. Number WO2006/058017

Priority 60/630,363 22.11.04 US

Filing date 21 November 2005

Wipo publication date 1 June 2006

Acceptance publication date 12 May 2011

International Classifications

A61K 36/22 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/058017 Priority application(s): WO2006/058017

14 October 2010 Assignment before Grant

  Levine, William; Izun Pharmaceuticals Corporation The application has been assigned to Izun Pharmaceuticals Corporation

12 May 2011 Application Accepted

  Published as AU-B-2005309652

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309653-Implant device used in mimimally invasive facet joint hemi-arthroplasty

2005309651-Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin